跳至主要内容
临床试验/CTRI/2024/10/074613
CTRI/2024/10/074613尚未招募2/3 期

Effect of Trikatu choorna in the management of Medo Dushti W.S.R to Primary Hyper Triglyceridemia An open lable clinical trial

Dr Pradnya Prakash Hemke1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To evaluate efficacy of Trikatu churna in Medo dushti through triglyceride levels.

研究概览

简要总结

The term dyslipidaemia denotes disorders of lipid metabolism Majority of the population is following inappropriate fatty diet regimen and sedentary lifestyle which may lead to a state of dyslipidaemia Dyslipidaemia denotes the state where there can be overproduction or decrease in production of lipoprotein The crude HTG prevalence rates were 29.6% in global population 36.9% in men and 23.8% in women The sex and age adjusted HTG prevalence rates were 27.0% in global population34.6% in men and 21.4% in women A fifth of the female adult population and more than a third of the male population had HTG The prevalence rates of various fasting dyslipidaemia in the first phase of ICMR INDIAN study restricted to urban and rural populations in 4 states in India was hypercholesterolemia in 13.9%, high triglycerides in 29.5% low HDL cholesterol in 72.3% and high LDL cholesterol in 11.8% 79%men and women had abnormalities in at least one of the lipid parameters Triglycerides are fatty acids and denotes the main lipid component of dietary fat They store unused calories and provide your body with energy  According to AMERICAN HEART HEALTH(AHA)factors affecting the triglyceride includes Diet Exercise level Diabetes  Inflammatory disease  Alcohol consumption  Obesity  Medications  Age  Sex  Pregnancy  The normal level of triglycerides in blood 150mg/dl (Acc National Cholesterol Education Program Adult Treatment Panel III) Normal <150 Borderline 150-199 High 200-499 Very high >500 Hypertriglyceridemia (HG) is an independent risk factor with more prevalence than hypercholesterolemia and its attributes to cardiovascular disease (CVD) and pancreatitis Hence it becomes imperative to search for new triglyceride (TG) lowering agents In Ayurveda  medodushti is pathological event which causes sthoulya which comes under Ashtanindita  The Ayurvedic description of Medodushtijanya Sign and  Symptoms bears a remarkable resemblance to the current texts explanation of dyslipidemia  As stated According to Ayurveda a diet high in Shleshma Vardhak Ahara Vihara and low in exercise lead to Agnidushti which in turn causes an excess of Sama Meda to form  As a result Medovriddhi  and  Medodushti  appears   Acharya Sushruta explained TRIKATU which consist of 3 drugs PIPALLI (PIPER LONGUM)  MARICH (PIPER NIGRUM) SHUNTHI (ZINGIBER OFFINCINALE) as kaphomedaghna  Sharangdhar explains trikatu as dipana shleshma MEDOGHNA6 kushta pinasnashanam which means drugs which do agni dipana and reduces excess of meda The drugs present in trikatu mainly has KATU RASA and USHNA VEERYA  Katu rasa will scrape the meda in the strotas and usna veerya will do pachan of the meda  Building certainty on simple formulation and minimal expenses with high compelling treatment is need of the time  Keeping this in view trikatu choorna capsule with compelling dose is considered for the ongoing review

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Triglyceride level-Borderline 150-199mg/dl Individuals of either sex between 20-60 years of age BMI-More than 25 Individual fulfilling subjective criteria.

排除标准

  • Thyroid disorder Hypertension Diabetes Kidney disease Other systemic and genetic disease Pregnant and lactating women Grishma rutu Pitta prakopita individual.

结局指标

主要结局

To evaluate efficacy of Trikatu churna in Medo dushti through triglyceride levels.

时间窗: Baseline and 42nd day

次要结局

  • To assess improvement in other lipid parameters along with subjective parameters.(Baseline 21st day and 42nd day)

研究者

发起方
Dr Pradnya Prakash Hemke
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pradnya Prakash Hemke

Kahers Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi Karnataka 590003

研究点 (1)

Loading locations...

相似试验